SAEC Names New Partners, Launches Stage II | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium (SAEC) announced today four new partners that have joined the initiative as it launches Stage II of its research efforts.

The new partners are the University of Liverpool and Newcastle University — both which were announced as partners earlier this month — the HMO Research Network, and Cerner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."